Vincerx Pharma, Inc. (VINC) Misses Q3 EPS by 25c
Tweet
Share
E-mailGet Alerts VINC Hot Sheet
Join SI Premium – FREE
Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q3 EPS of ($0.80), $0.25 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Argan (AGX) Tops Q2 EPS by 110c
- Broadcom (AVGO) Tops Q3 EPS by 11c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
